LitAlert ~~ GeneLit.com

    • PTEN rs701848 Polymorphism is associated with Trastuzumab Resistance in HER2-positive Metastatic Breast Cancer and predicts Progression-free survival.
    • El-Khazragy N, Gaballah A, Bakkar A, Hemida EHA, Samir N, Tarek M, Adly HM, Saleh SAK,Hanna DH.
    • Clin Breast Cancer. 2022 Dec 20:S1526-8209(22)00288-9. doi: 10.1016/j.clbc.2022.12.010. Epub ahead of print.

    • The potential of PARP inhibitors in targeted cancer therapy and immunotherapy.
    • Hunia J, Gawalski K, Szredzka A, Suskiewicz MJ, Nowis D.
    • Front Mol Biosci. 2022 Dec 1;9:1073797. doi: 10.3389/fmolb.2022.1073797.

    • Predictive factors for relapse in triple-negative breast cancer patients without pathological complete response after neoadjuvant chemotherapy.
    • Toss A, Venturelli M, Civallero M, Piombino C, Domati F, Ficarra G, Combi F, Cabitza E, Caggia F, Barbieri E, Barbolini M, Moscetti L, Omarini C, Piacentini F, Tazzioli G, Dominici M, Cortesi L.
    • Front Oncol. 2022 Dec 1;12:1016295. doi: 10.3389/fonc.2022.1016295.